Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Lexeo Therapeutics (LXEO) Assets Average (2023 - 2026)

Lexeo Therapeutics' Assets Average history spans 1 years, with the latest figure at $97.3 million for Q4 2023.

  • On a quarterly basis, Assets Average changed N/A to $97.3 million in Q4 2023 year-over-year; TTM through Dec 2023 was $97.3 million, a N/A change, with the full-year FY2023 number at $118.4 million, changed N/A from a year prior.
  • Assets Average hit $97.3 million in Q4 2023 for Lexeo Therapeutics.
  • Over the last five years, Assets Average for LXEO hit a ceiling of $97.3 million in Q4 2023 and a floor of $97.3 million in Q4 2023.